From Reuters: The U.S. Food and Drug Administration said on Saturday certain lots of the supplement L-citrulline, used to treat genetic disorders found mostly in children, sold by compounding firm Medisca Inc were found to contain none of the drug, and warned doctors and patients not to use it.
“Urea cycle disorders are rare, affecting between 2,000 and 2,500 children in the U.S. About 75 percent of those people may require L-citrulline supplements“, said Cynthia Le Mons, executive director of the National Urea Cycle Disorders Foundation in Pasadena, Calif.
URGENT DRUG RECALL – MEDISCA CITRULLINE: Medisca has just issued a recall of citrulline lots 95482/A, 95482/B, 95482/C, 95482/D, 96453/A, 96453/B, 96453/C, 96453/
If you have any of the affected lots, please report here.
For more information, please visit NUCDF.org or their Facebook page for urgent updates.